title: [Glycine in the treatment of trigeminal neuralgia].
abstract: As many as 98 patients suffering from trigeminal neuralgia were given myeglynol (glycine) in a dose of 110 mg/kg a day for 4-5 weeks. A noticeable effect manifesting in the counteracting painful paroxysms was attained in more than 86% of cases. The drug was administered alone at the disease onset. The treatment effect of myeglynol may be related to its capacity to decrease to normal the high concentration of formaldehyde in the blood serum of patients suffering from trigeminal neuralgia.
authors.forename: R S
authors.initials: RS
authors.lastname: Megdiatov
authors.forename: V A
authors.initials: VA
authors.lastname: Karlov
authors.forename: Iu N
authors.initials: IuN
authors.lastname: Savchenko
authors.forename: A P
authors.initials: AP
authors.lastname: Khokhlov
mesh_terms: D000284:Administration, Oral; D000328:Adult; D000368:Aged; D004334:Drug Administration Schedule; D005260:Female; D005998:Glycine / Q000008:administration & dosage*; D006801:Humans; D008875:Middle Aged; D014277:Trigeminal Neuralgia / Q000188:drug therapy*
chemical_list: D005998:Glycine
vernacular_title: Glitsin v lechenii nevralgii troĭnichnogo nerva.